Hyperion Therapeutics To Present At Needham's 12th Annual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., April 25, 2013 (GLOBE NEWSWIRE) -- Hyperion Therapeutics (Nasdaq:HPTX) announced today that the company is scheduled to present at Needham's 12 th Annual Healthcare Conference on Tuesday, April 30 at 9:20 a.m. ET.

Donald J. Santel, Chief Executive Officer of Hyperion, will provide a company overview. To access the live webcast and subsequent archived recording, please visit Hyperion's website at http://investors.hyperiontx.com/events.cfm .

About Hyperion Therapeutics

Hyperion Therapeutics, Inc. is a commercial stage biopharmaceutical company committed to developing and delivering life-changing treatments for orphan diseases and hepatology.
CONTACT: Shari Annes, Investor Relations         (650) 888-0902         sannes@annesassociates.com                  Kristie Kuhl, Media Relations         (203) 556-7417         kkuhl@makovsky.com